Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

14
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
14
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Haemodynamic predictors of early aortic growth in uncomplicated type B dissection: a cohort study.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Untreated mild-moderate mitral regurgitation after isolated aortic valve replacement for aortic stenosis.

Journal of cardiothoracic surgery·2026
Same author

Short- and Mid-Term Outcomes of Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation in Octogenarians.

Circulation reports·2026
Same author

Incidence, Timing, and Determinants of Stroke After Mitral Repair in Patients Without Preoperative Atrial Fibrillation.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Zone 1 total arch replacement with frozen elephant trunk for type A dissection: early-to-mid-term outcomes.

Journal of cardiothoracic surgery·2026
Same author

Evaluation of segmentation accuracy and the improvement of time effectiveness using deep learning-based segmentation in <sup>177</sup>Lu-DOTATATE dosimetry.

EJNMMI physics·2026

相关实验视频

Updated: Jul 18, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.4K

心肌炎治疗中的范式转变

Ulugbek Yakhshimurodov1, Kizuku Yamashita1, Takuji Kawamura1

  • 1Department of Cardiovascular Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Journal of cardiology
|August 19, 2023
PubMed
概括

心肌炎可能导致心脏突然死亡和慢性心脏病. 新兴的基于细胞的疗法在动物模型中显示出降低炎症和改善心脏功能的前景.

科学领域:

  • 心脏病学 心脏病学
  • 再生医学是一种再生医学.

背景情况:

  • 心肌炎是年轻人突然心脏死亡的重要原因,并可能导致扩张性心肌病.
  • 目前心肌炎的治疗方法包括支持性护理和特定的病因疗法,如某些自身免疫或药物诱导形式的免疫抑制.
  • 传统的治疗方法有局限性,这促使人们研究新的治疗方法.

研究的目的:

  • 审查心肌炎治疗的不断变化的格局.
  • 突出再生医学的潜力,特别是基于细胞的疗法,用于治疗心肌炎及其并发症.

主要方法:

  • 审查当前治疗心肌炎的治疗策略.
  • 在动物模型中分析评估干细胞治疗心肌炎的研究.

主要成果:

  • 基于细胞的疗法在实验模型中显示,可以减少炎症和心肌纤维化.
  • 干细胞治疗显示出在预防心衰竭和与心肌炎相关的不良心脏重塑方面有潜力.

结论:

  • 基于再生细胞和组织的疗法代表了心肌炎治疗的有希望的进步.
  • 对基于细胞的治疗方法的进一步研究可能为治疗急性心肌炎及其慢性后果提供新的途径.
关键词:
细胞疗法是一种细胞疗法.扩展性心肌病变性是指扩展性心肌病变性.巨细胞是一个巨细胞.肌心炎是一种心肌炎.干细胞是一种干细胞.

更多相关视频

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.0K

相关实验视频

Last Updated: Jul 18, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.4K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.0K